Literature DB >> 30005933

A meta-analysis of factors associated with quality of life in first episode psychosis.

Philip Watson1, Jian-Ping Zhang2, Asra Rizvi3, Jonathan Tamaiev4, Michael L Birnbaum2, John Kane2.   

Abstract

OBJECTIVE: Improving quality of life for people with first episode psychosis is an important aspect of recovery. Our objective was to review the associative factors on quality of life in first episode psychosis. A meta-analysis was conducted on the associations between quality of life, symptom severity, and duration of untreated psychosis.
METHOD: Fifty-one articles were identified (published through 08/29/2016) that provided data on the relationship between quality of life and at least one other outcome measure of interest in first episode psychosis. Of those studies, 21 were included in a meta-analysis (n = 3992) of the relationship between quality of life, severity of psychosis, and duration of untreated psychosis.
RESULTS: Meta-analysis identified significant negative correlations between quality of life and severity of symptoms (total symptom scores: r = -0.32, p < 0.001) and quality of life and duration of untreated psychosis (r = -0.21, p < 0.001). Heinrich's quality of life scale emerged as being more sensitive to the presence of psychotic symptoms than other measures of quality of life.
CONCLUSIONS: Associations were found between certain disease specific variables and quality of life in first episode psychosis, highlighting the relationship between symptom presentation and quality of life and the need for early intervention. Proper assessment of quality of life is important to promote improved quality of life in patients with first episode psychosis. Future research is needed to examine the interacting effects of symptom presentation, duration of untreated psychosis, and other variables, such as neurocognition, on quality of life.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  First episode; Meta-analysis; Psychosis; Quality of life; Schizophrenia

Mesh:

Year:  2018        PMID: 30005933     DOI: 10.1016/j.schres.2018.07.013

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  17 in total

Review 1.  New Antipsychotic Medications in the Last Decade.

Authors:  Mehak Pahwa; Ahmad Sleem; Omar H Elsayed; Megan Elizabeth Good; Rif S El-Mallakh
Journal:  Curr Psychiatry Rep       Date:  2021-11-29       Impact factor: 5.285

2.  Social motivation and behavior in first-episode psychosis: Unique contributions to social quality of life and social functioning.

Authors:  Aubrey M Moe; David M Weiss; Jacob G Pine; Heather M Wastler; Nicholas J K Breitborde
Journal:  J Psychiatr Res       Date:  2021-11-03       Impact factor: 4.791

3.  Quality of life in first episode psychosis: a cluster analytic approach.

Authors:  Z Liao; K Allott; J F I Anderson; E Killackey; S M Cotton
Journal:  Qual Life Res       Date:  2021-10-18       Impact factor: 4.147

4.  Brexpiprazole Reduces 5-HT7 Receptor Function on Astroglial Transmission Systems.

Authors:  Kouji Fukuyama; Eishi Motomura; Motohiro Okada
Journal:  Int J Mol Sci       Date:  2022-06-12       Impact factor: 6.208

5.  Taking a Look at How Family Member Engagement Influences Service User Engagement in New Journeys: a Coordinated Specialty Care Program.

Authors:  Oladunni Oluwoye; Elizabeth R Fraser; Gordon Kordas
Journal:  J Behav Health Serv Res       Date:  2022-03-31       Impact factor: 1.475

6.  The clinical significance of duration of untreated psychosis: an umbrella review and random-effects meta-analysis.

Authors:  Oliver D Howes; Thomas Whitehurst; Ekaterina Shatalina; Leigh Townsend; Ellis Chika Onwordi; Tsz Lun Allenis Mak; Atheeshaan Arumuham; Oisín O'Brien; Maria Lobo; Luke Vano; Uzma Zahid; Emma Butler; Martin Osugo
Journal:  World Psychiatry       Date:  2021-02       Impact factor: 49.548

7.  Clinical Effects of Mindfulness-Based Intervention in Patients With First Episode Psychosis and in Individuals With Ultra-High Risk for Transition to Psychosis: A Review.

Authors:  Philippe Vignaud; Karen T Reilly; Clément Donde; Frédéric Haesebaert; Jérôme Brunelin
Journal:  Front Psychiatry       Date:  2019-10-31       Impact factor: 4.157

8.  Early recovery in the first 24 months of treatment in first-episode schizophrenia-spectrum disorders.

Authors:  Lebogang Phahladira; Hilmar K Luckhoff; Laila Asmal; Sanja Kilian; Frederika Scheffler; Stefan du Plessis; Bonginkosi Chiliza; Robin Emsley
Journal:  NPJ Schizophr       Date:  2020-01-08

9.  Identification of Risk Factors to Predict the Occurrences of Relapses in Individuals with Schizophrenia Spectrum Disorder in Iran.

Authors:  Omran Davarinejad; Tahereh Mohammadi Majd; Farzaneh Golmohammadi; Payam Mohammadi; Farnaz Radmehr; Mostafa Alikhani; Tayebeh Motaei; Mehdi Moradinazar; Annette Brühl; Dena Sadeghi Bahmani; Serge Brand
Journal:  Int J Environ Res Public Health       Date:  2021-01-11       Impact factor: 3.390

10.  Relationship of subjective quality of life with symptomatology, neurocognition and psychosocial functioning in first-episode psychosis: a structural equation modelling approach.

Authors:  Sandra Chi Yiu Wong; Wing Chung Chang; Christy Lai Ming Hui; Sherry Kit Wa Chan; Edwin Ho Ming Lee; Yi Nam Suen; Eric Yu Hai Chen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-07-25       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.